Cost Considerations with Tight Glycemic Control in the Acute Care Setting

Seminars in Thoracic and Cardiovascular Surgery

Volumn 18, Issue 4, 2006, Pages 359-365

  Hilleman, Daniel E ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

cost effective; health care resource utilization analysis; pharmacoeconomics; tight glycemic control protocols

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INFLUENZA VACCINE; INSULIN;

ACUTE HEART INFARCTION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GLUCOSE MONITORING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS SURGERY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG TARGETING; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; INSULIN TREATMENT; INTENSIVE CARE; KIDNEY FAILURE; LENGTH OF STAY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE INFECTION; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; RISK REDUCTION; WOUND INFECTION;

BLOOD GLUCOSE; CARDIAC SURGICAL PROCEDURES; COSTS AND COST ANALYSIS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INTENSIVE CARE; INTENSIVE CARE UNITS; MYOCARDIAL INFARCTION; UNITED STATES;

EID: 33947528255     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2006.12.004     Document Type: Article

References (28)

1. http://www.cato.org/pubs/pas/pa527.pdf. Accessed September 24, 2006
2. http://www.ahcpr.gov/research/costix.htm. Accessed September 24, 2006
3. Garber A.J., Moghissi E.S., Bransome E.D., et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endor Pract 10 (2004) 77-82
4. Kupersmith J., Holmes-Rovner M., Hogan A., et al. Cost-effectiveness analysis in heart disease, Part I: general principles. Prog Cardiovasc Dis 38 (1994) 161-184
5. Tengs T.O., Adams M.E., Pliskin J.S., et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 15 (1995) 369-390
6. Bridges C.B., Thompson W.W., Meltzer M.I., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284 (2000) 1655-1663
7. ™ 2006, version 3.12, Medi-Span, Inc., Wolters Kluwer Health, Indianapolis, IN
8. Current Procedural Terminology (CPT) (2006), American Medical Association, Chicago, IL
9. Mushlin A.I., Hall W.J., Zwanziger J., et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Circulation 97 (1998) 2129-2135
10. Agency for Healthcare Research and Quality, Rockville, MD, Healthcare Cost and Utilization Project (HCUP) database (online). Available from URL. http://www.ahrq.gov/data/hcup/hcup-pkt.htm. Accessed September 28, 2006
11. Fath-Ordoubadi F., and Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96 (1997) 1152-1156
12. Mehta S.R., Yusuf S., Diaz R., et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ELCA randomized controlled trial. JAMA 293 (2005) 437-446
13. Malmberg K., Ryden L., Efendic S., Herlitz J., et al., DIGAMI study group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
14. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI-2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
15. Almbrand B., Johannesson M., Sjostrand B., et al. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus: results from the DIGAMI study. Eur Heart J 21 (2000) 733-739
16. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight gycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109 (2004) 1497-1502
17. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 (1999) 352-362
18. Furnary A.P., Gao G.H., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
19. Furnary A.P., Wu Y., and Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10 suppl 2 (2004) 21-33
20. Vora A.C., Saleem T.M., Polomano R.C., et al. Improved perioperative glycemic control by continuous insulin infusion under supervision of an endocrinologist does not increase costs in patients with diabetes. Endocr Pract 10 (2004) 112-118
21. Estrada C.A., Young J.A., Nifong L.W., et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 75 (2003) 1392-1399
22. Polverejan E., Gardiner J.C., Bradley C.J., et al. Estimating mean hospital cost as a function of length of stay and patient characteristics. Health Econ 12 (2003) 935-947
23. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
24. Van den Berghe G., Wouters P.J., Kesteloot K., et al. Analysis of healthcare resource utilization with intensive insulin therapy in criticall ill patients. Crit Care Med 34 (2006) 612-616
25. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 8 (2004) 992-1000
26. Krinsley J.S., and Jones R.L. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 129 (2006) 644-650
27. Levetan C.S., Salas J.R., Wilets I.F., et al. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 99 (1995) 22-28
28. Levetan C.S., Passaro M.D., Jablonski K.A., et al. Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care 22 (1999) 1790-1795